August J. Troendle - 22 May 2024 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Issuer symbol: MEDP
Transactions as of: 22 May 2024
Transactions value $: -$22,000
Form type: 4
Filing time: 24 May 2024, 16:10:51 UTC
Previous filing: 22 May 2024
Next filing: 29 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MEDP	Common Stock	Sale	-$22,000	-55	-0.01%	$400	664,338	22 May 2024	Direct	F1
holding	MEDP	Common Stock						4,733,019	22 May 2024	By Medpace Investors, LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction reported on this Form 4 was effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2	The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Content

The transaction reported on this Form 4 was effected pursuant to a limit order placed by the Reporting Person during an open window period.

The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.